ストックスクリーナーアプリを入手
4.91
2.00%
-0.10
アフターアワーズ：
4.89
-0.02
-0.41%
Ardelyx Inc (ARDX) 最新ニュース
ARDX Investors Have Opportunity to Lead Ardelyx, Inc.Securities Fraud Lawsuit with the Schall Law Firm - GuruFocus.com
Recent 15% pullback isn't enough to hurt long-term Ardelyx (NASDAQ:ARDX) shareholders, they're still up 504% over 3 years - Simply Wall St
Ardelyx (NASDAQ:ARDX) Given "Neutral" Rating at HC Wainwright - MarketBeat
Ardelyx, Inc. (NASDAQ:ARDX) Shares Purchased by Hennion & Walsh Asset Management Inc. - MarketBeat
Ardelyx (NASDAQ:ARDX) Shares Up 8.3%Still a Buy? - MarketBeat
Ardelyx (NASDAQ:ARDX) Stock Price Down 3.7%Time to Sell? - MarketBeat
Ardelyx (ARDX) Moves 16.0% Higher: Will This Strength Last? - MSN
Ardelyx (NASDAQ:ARDX) Stock Price Up 8.3%What's Next? - MarketBeat
Ardelyx's Ibsrela sales beat expectations, shares surge By Investing.com - Investing.com Canada
Ardelyx reports strong 2024 sales, eyes growth in 2025 By Investing.com - Investing.com Canada
Ardelyx provides update on commercial progress; shares up 8% - MSN
Ardelyx reports strong 2024 sales, eyes growth in 2025 - Investing.com
Ardelyx Provides Update on Increasing Commercial Momentum and 2025 Strategic Priorities - The Manila Times
Ardelyx Reports Strong 2024: IBSRELA, XPHOZAH Drive $319M Revenue as Growth Accelerates - StockTitan
Ardelyx CEO Michael Raab sells $221k in stock - Investing.com India
Ardelyx CEO Michael Raab sells $221k in stock By Investing.com - Investing.com Australia
Ardelyx, Inc. (NASDAQ:ARDX) CEO Michael Raab Sells 41,666 Shares - MarketBeat
Ardelyx (NASDAQ:ARDX) Shares Up 5.8%Should You Buy? - MarketBeat
Ardelyx to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Ardelyx CEO to Present at JP Morgan Healthcare Conference 2025 in San Francisco - StockTitan
Ardelyx, Inc. (NASDAQ:ARDX) Receives $10.07 Average PT from Brokerages - MarketBeat
Principal Financial Group Inc. Has $933,000 Stock Holdings in Ardelyx, Inc. (NASDAQ:ARDX) - MarketBeat
Beyond The Numbers: 4 Analysts Discuss Ardelyx Stock - Benzinga
Jefferies Financial Group Issues Pessimistic Forecast for Ardelyx (NASDAQ:ARDX) Stock Price - MarketBeat
(ARDX) Investment Analysis - Stock Traders Daily
Ardelyx (NASDAQ:ARDX) Stock Price Down 3.8%Here's Why - MarketBeat
Why Ardelyx (ARDX) Is One of the Best Biotech Penny Stocks to Invest in Now? - Insider Monkey
Exploring 3 High Growth Tech Stocks in the United States - Simply Wall St
Lost Money on Ardelyx, Inc.(ARDX)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - The Eastern Progress Online
Ardelyx (NASDAQ:ARDX) Stock Price Up 4.6%What's Next? - MarketBeat
US Penny Stocks To Watch In December 2024 - Simply Wall St
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates C - GuruFocus.com
Ardelyx (NASDAQ:ARDX) Shares Gap Up After Insider Buying Activity - MarketBeat
Ardelyx, Inc. (NASDAQ:ARDX) Director David M. Mott Purchases 213,300 Shares - MarketBeat
Ardelyx director David Mott buys $996,580 in stock By Investing.com - Investing.com Nigeria
Ardelyx director David Mott buys $996,580 in stock - Investing.com
Ardelyx, Inc. (NASDAQ:ARDX) Shares Bought by Barclays PLC - MarketBeat
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - The Eastern Progress Online
Ardelyx: A Small Bet Its Latest Setback Will Be Temporary (NASDAQ:ARDX) - Seeking Alpha
4.81%
大文字化:
|
ボリューム (24 時間):